341 related articles for article (PubMed ID: 22392319)
1. What should we know about metabolic syndrome and lipodystrophy in AIDS?
Signorini DJ; Monteiro MC; Andrade Mde F; Signorini DH; Eyer-Silva Wde A
Rev Assoc Med Bras (1992); 2012; 58(1):70-5. PubMed ID: 22392319
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of metabolic syndrome among antiretroviral-naive and antiretroviral-experienced HIV-1 infected Thai adults.
Jantarapakde J; Phanuphak N; Chaturawit C; Pengnonyang S; Mathajittiphan P; Takamtha P; Dungjun N; Pinyakorn S; Pima W; Prasithsirikul W; Phanuphak P
AIDS Patient Care STDS; 2014 Jul; 28(7):331-40. PubMed ID: 24914459
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A
Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of highly active antiretroviral therapy associated metabolic abnormalities and lipodystrophy in HIV infected patients.
Feleke Y; Fekade D; Mezegebu Y
Ethiop Med J; 2012 Jul; 50(3):221-30. PubMed ID: 23409405
[TBL] [Abstract][Full Text] [Related]
5. Burden of metabolic syndrome among HIV-infected patients in Southern Ethiopia.
Tesfaye DY; Kinde S; Medhin G; Megerssa YC; Tadewos A; Tadesse E; Shimelis T
Diabetes Metab Syndr; 2014; 8(2):102-7. PubMed ID: 24907175
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and factors associated with lipodystrophy in AIDS patients.
Justina LB; Luiz MC; Maurici R; Schuelter-Trevisol F
Rev Soc Bras Med Trop; 2014; 47(1):30-7. PubMed ID: 24603734
[TBL] [Abstract][Full Text] [Related]
7. The metabolic syndrome, an epidemic among HIV-infected patients on HAART.
Jevtović DJ; Dragović G; Salemović D; Ranin J; Djurković-Djaković O
Biomed Pharmacother; 2009 Jun; 63(5):337-42. PubMed ID: 18996676
[TBL] [Abstract][Full Text] [Related]
8. Metabolic syndrome in HIV-infected patients from an urban, midwestern US outpatient population.
Mondy K; Overton ET; Grubb J; Tong S; Seyfried W; Powderly W; Yarasheski K
Clin Infect Dis; 2007 Mar; 44(5):726-34. PubMed ID: 17278068
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of diabetes mellitus, hyperinsulinaemia and metabolic syndrome among 755 adult patients with HIV-1 infection.
Calza L; Masetti G; Piergentili B; Trapani F; Cascavilla A; Manfredi R; Colangeli V; Viale P
Int J STD AIDS; 2011 Jan; 22(1):43-5. PubMed ID: 21364066
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study.
Friis-Møller N; Weber R; Reiss P; Thiébaut R; Kirk O; d'Arminio Monforte A; Pradier C; Morfeldt L; Mateu S; Law M; El-Sadr W; De Wit S; Sabin CA; Phillips AN; Lundgren JD;
AIDS; 2003 May; 17(8):1179-93. PubMed ID: 12819520
[TBL] [Abstract][Full Text] [Related]
11. Lipodystrophy and metabolic abnormalities in Slovenian HIV-infected patients.
Tomazic J; Silic A; Karner P; Vidmar L; Maticic M; Poljak M; Ihan A; Janez A
Wien Klin Wochenschr; 2004 Nov; 116(21-22):755-9. PubMed ID: 15628647
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of lipodystrophy and metabolic syndrome among HIV positive individuals on Highly Active Anti-Retroviral treatment in Jimma, South West Ethiopia.
Berhane T; Yami A; Alemseged F; Yemane T; Hamza L; Kassim M; Deribe K
Pan Afr Med J; 2012; 13():43. PubMed ID: 23330034
[TBL] [Abstract][Full Text] [Related]
13. Metabolic and body composition changes after six months of highly active antiretroviral therapy in northern Indian patients.
Gupta V; Biswas A; Sharma SK
Int J STD AIDS; 2011 Jan; 22(1):46-9. PubMed ID: 21364067
[TBL] [Abstract][Full Text] [Related]
14. Lipodystrophy and metabolic disorders in HIV-1-infected adults on 4- to 9-year antiretroviral therapy in Senegal: a case-control study.
Mercier S; Gueye NF; Cournil A; Fontbonne A; Copin N; Ndiaye I; Dupuy AM; Cames C; Sow PS; Ndoye I; Delaporte E; Simondon KB
J Acquir Immune Defic Syndr; 2009 Jun; 51(2):224-30. PubMed ID: 19339897
[TBL] [Abstract][Full Text] [Related]
15. Features of Metabolic Syndrome and Its Associated Factors during Highly Active Antiretroviral Therapy in Ouagadougou (Burkina Faso).
Guira O; Tiéno H; Diendéré AE; Sagna Y; Diallo I; Yaméogo B; Zoungrana L; Yaméogo TM; Bognounou R; Drabo JY
J Int Assoc Provid AIDS Care; 2016; 15(2):159-63. PubMed ID: 26307211
[TBL] [Abstract][Full Text] [Related]
16. Lipodystrophy among HIV-infected children and adolescents on highly active antiretroviral therapy in Uganda: a cross sectional study.
Piloya T; Bakeera-Kitaka S; Kekitiinwa A; Kamya MR
J Int AIDS Soc; 2012 Jul; 15(2):17427. PubMed ID: 22814353
[TBL] [Abstract][Full Text] [Related]
17. Impact of Lipodystrophy on the prevalence and components of metabolic syndrome in HIV-infected patients.
Freitas P; Carvalho D; Souto S; Santos AC; Xerinda S; Marques R; Martinez E; Sarmento A; Medina JL
BMC Infect Dis; 2011 Sep; 11():246. PubMed ID: 21933422
[TBL] [Abstract][Full Text] [Related]
18. Metabolic syndrome in French HIV-infected patients: prevalence and predictive factors after 3 years of antiretroviral therapy.
Biron A; Bobin-Dubigeon C; Volteau C; Piroth L; Perré P; Leport C; Prazuck T; Jovelin T; Billard M; Sébille V; Bard JM; Raffi F; Biron C
AIDS Res Hum Retroviruses; 2012 Dec; 28(12):1672-8. PubMed ID: 22731114
[TBL] [Abstract][Full Text] [Related]
19. Lipodystrophy - a sign for metabolic syndrome in patients of the HIV-HEART study.
Potthoff A; Brockmeyer NH; Gelbrich G; Neuhaus K; Esser S; Reinsch N; Hower M; Mostardt S; Neumann A; Neumann T;
J Dtsch Dermatol Ges; 2010 Feb; 8(2):92-8. PubMed ID: 20002869
[TBL] [Abstract][Full Text] [Related]
20. [Prevalence of HIV-associated lipodystrophy in Brazilian outpatients: relation with metabolic syndrome and cardiovascular risk factors].
Diehl LA; Dias JR; Paes AC; Thomazini MC; Garcia LR; Cinagawa E; Wiechmann SL; Carrilho AJ
Arq Bras Endocrinol Metabol; 2008 Jun; 52(4):658-67. PubMed ID: 18604379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
